For moderate headaches during normal titration, most prescribers recommend maintaining the current dose for an extended period (pausing escalation for 46 weeks) rather than reducing it, because this allows physiological adaptation to complete
Always follow your providers instructions and report symptoms promptly
Possible experiences: strong appetite regulation, 8 to 12 pounds cumulative weight loss, noticeable clothing fit changes, may experience more pronounced GI effects at this increase
The wearing-off period shifts to the weekend, when you might have more control over your food environment and can implement the dietary strategies discussed earlier
Tirzepatide, a dual GIP and GLP-1 receptor agonist approved by the FDA for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound), may indirectly affect menstrual cycles in some women